Eastgate Biotech Corp. (ETBI)
Eastgate Biotech Corp. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $5.6M. On trailing twelve-month figures it carries a trailing P/E of -1.42, a net margin of -3553.7%. Its beta of 3.42 implies it has historically moved more than the broad market.
EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.
Eastgate Biotech Corp. is most often compared with the following Healthcare names: